Foxo Technologies Inc
FOXO0.092USD
0.000
Close 12/24, 13:00（ET）Quotes delayed by 15 min
31.56KMarket Cap
LossP/E TTM
More Details of Foxo Technologies Inc Company
FOXO Technologies Inc. is engaged in commercializing epigenetic biomarker technology to support groundbreaking scientific research and next-generation business initiatives. The Company owns and operates three subsidiaries: Foxo Labs, Inc., Myrtle Recovery Centers, Inc., and Rennova Community Health, Inc. It applies automated machine learning and artificial intelligence (AI) technologies to discover epigenetic biomarkers of human health, wellness and aging. Its segments include Healthcare and Labs and Life. The Healthcare segment offers behavioral health services, including substance abuse treatment. Services are provided on either an inpatient, residential basis or an outpatient basis. It offers alcohol and drug residential detoxification and residential rehabilitation treatment services for up to 30 patients. The Labs and Life segment is commercializing proprietary epigenetic biomarker technology to be used for underwriting risk classification in the global life insurance industry.
Foxo Technologies Inc Info
Ticker SymbolFOXO
Company nameFoxo Technologies Inc
IPO dateDec 11, 2020
CEOMr. Seamus Lagan
Number of employees- -
Security typeOrdinary Share
Fiscal year-endDec 11
Address477 South Rosemary Avenue
CityWEST PALM BEACH
Stock exchangeUS 'Other OTC' and Grey Market
CountryUnited States of America
Postal code33401
Phone16128000059
Websitehttp://delwinds.com/
Ticker SymbolFOXO
IPO dateDec 11, 2020
CEOMr. Seamus Lagan
Company Executives of Foxo Technologies Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Bret Barnes
Mr. Bret Barnes
Director
Director
168.00
+0.60%
Mr. Mark K. White
Mr. Mark K. White
Chief Executive Officer and sole director of FOXO Labs Inc. and Director
Chief Executive Officer and sole director of FOXO Labs Inc. and Director
--
--
Mr. Seamus Lagan
Mr. Seamus Lagan
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Trevor Langley
Mr. Trevor Langley
Chairman of the Board
Chairman of the Board
--
--
Mr. Francis Colt Dewolf, III
Mr. Francis Colt Dewolf, III
Independent Director
Independent Director
--
--
Sylwia Hauman
Sylwia Hauman
Chief Financial Officer
Chief Financial Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Bret Barnes
Mr. Bret Barnes
Director
Director
168.00
+0.60%
Mr. Mark K. White
Mr. Mark K. White
Chief Executive Officer and sole director of FOXO Labs Inc. and Director
Chief Executive Officer and sole director of FOXO Labs Inc. and Director
--
--
Mr. Seamus Lagan
Mr. Seamus Lagan
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Trevor Langley
Mr. Trevor Langley
Chairman of the Board
Chairman of the Board
--
--
Mr. Francis Colt Dewolf, III
Mr. Francis Colt Dewolf, III
Independent Director
Independent Director
--
--
Sylwia Hauman
Sylwia Hauman
Chief Financial Officer
Chief Financial Officer
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Thu, Dec 4
Updated: Thu, Dec 4
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Rennova Health, Inc.
0.07%
Kr8 ai Inc
0.02%
Other
99.92%
Shareholders
Shareholders
Proportion
Rennova Health, Inc.
0.07%
Kr8 ai Inc
0.02%
Other
99.92%
Shareholder Types
Shareholders
Proportion
Corporation
0.08%
Other
99.92%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
34
103.47K
0.13%
+57.49K
2025Q2
43
122.62K
2.30%
-40.72K
2025Q1
44
283.42K
16.93%
-74.76K
2024Q4
45
2.97M
12.59%
-305.11K
2024Q3
42
2.93M
22.70%
-1.57M
2024Q2
66
3.17M
26.93%
-1.03M
2024Q1
108
4.13M
45.76%
-1.73M
2023Q4
115
3.33M
41.62%
-1.13M
2023Q3
119
2.33M
33.97%
-1.67M
2023Q2
124
2.96M
79.90%
-804.39K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Rennova Health, Inc.
51.44K
0.07%
+2.00
+0.00%
Sep 10, 2025
Kr8 ai Inc
11.91K
0.02%
+1.00
+0.01%
Sep 10, 2025
Corbin Capital Partners, L.P.
1.38K
0%
--
--
Dec 31, 2024
Atalaya Capital Management LP
592.00
0%
--
--
Jun 30, 2024
Barnes (Bret)
168.00
0%
+1.00
+0.60%
Sep 10, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Nov 15, 2024
Merger
0→0
Oct 30, 2023
Merger
10→1
Oct 30, 2023
Merger
10→1
Oct 30, 2023
Merger
10→1
Oct 30, 2023
Merger
10→1
Date
Type
Ratio
Nov 15, 2024
Merger
0→0
Oct 30, 2023
Merger
10→1
Oct 30, 2023
Merger
10→1
Oct 30, 2023
Merger
10→1
Oct 30, 2023
Merger
10→1
FAQs
Who are the top five shareholders of Foxo Technologies Inc?
The top five shareholders of Foxo Technologies Inc are:
Rennova Health, Inc. holds 51.44K shares, accounting for 0.07% of the total shares.
Kr8 ai Inc holds 11.91K shares, accounting for 0.02% of the total shares.
Corbin Capital Partners, L.P. holds 1.38K shares, accounting for 0.00% of the total shares.
Atalaya Capital Management LP holds 592.00 shares, accounting for 0.00% of the total shares.
Barnes (Bret) holds 168.00 shares, accounting for 0.00% of the total shares.
Rennova Health, Inc. holds 51.44K shares, accounting for 0.07% of the total shares.
Kr8 ai Inc holds 11.91K shares, accounting for 0.02% of the total shares.
Corbin Capital Partners, L.P. holds 1.38K shares, accounting for 0.00% of the total shares.
Atalaya Capital Management LP holds 592.00 shares, accounting for 0.00% of the total shares.
Barnes (Bret) holds 168.00 shares, accounting for 0.00% of the total shares.
What are the top three shareholder types of Foxo Technologies Inc?
The top three shareholder types of Foxo Technologies Inc are:
Rennova Health, Inc.
Kr8 ai Inc
Other
Rennova Health, Inc.
Kr8 ai Inc
Other
How many institutions hold shares of Foxo Technologies Inc (FOXO)?
As of 2025Q3, 34 institutions hold shares of Foxo Technologies Inc, with a combined market value of approximately 103.47K, accounting for 0.13% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -2.16%.
What is the biggest source of revenue for Foxo Technologies Inc?
In --, the -- business generated the highest revenue for Foxo Technologies Inc, amounting to -- and accounting for --% of total revenue.
